Send Inquiry

Request To Call Back

Bortezomib Injection

Name: Bortezomib Injection
Brand: SCHWITZ BIOTECH

Get a Price/Quote

MOQ : 10000 Pieces

Bortezomib Injection Specification

Dosage Form
Lyophilized Powder for Injection

Expiration Date
24 months from date of manufacture

CAS No
179324-69-7

Indication
Multiple Myeloma and Mantle Cell Lymphoma

Appearance
White to off-white lyophilized powder

Storage
Store below 30°C, protect from light

Grade
Pharmaceutical Grade

Usage
Antineoplastic (cancer treatment)

Molecular Formula
C19H25BN4O4

Medicine Type
Allopathic

Dosage
2 mg/vial

Assay
Not less than 98.0%

Origin of Medicine
India

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Bortezomib as Bortezomib for Injection

Prescription Required
Yes

Packing Type
Glass Vial with Flip-off Seal

Shelf Life
2 years

Brand Name
Bortecad

Reconstitution Solvent
Sterile Water for Injection

Therapeutic Class
Antineoplastic Agent

Inactive Ingredients
Mannitol

Route of Administration
Intravenous or Subcutaneous

Strength
2 mg

Regulatory Status
WHO-GMP, ISO Certified

Available Strengths
2 mg, 3.5 mg

Bortezomib Injection Trade Information

Minimum Order Quantity
10000 Pieces

Payment Terms
Letter of Credit at Sight (Sight L/C), Cash on Delivery (COD), Cash Advance (CA)

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

Sample Available
No

About Bortezomib Injection

Bortezomib Injection

Bortenat 2mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Purpose and Indication

Bortecad (Bortezomib Injection) is primarily used as a first or subsequent treatment for adults with multiple myeloma or mantle cell lymphoma. As an antineoplastic agent, it works by interfering with the growth of cancer cells, helping to slow disease progression. This makes it a valuable option for patients in need of targeted cancer therapy.

Usage Instructions and Administration

This medication is administered intravenously or subcutaneously by a healthcare professional. Each vial is reconstituted with sterile water before injection. Dosage adjustments and schedules are determined by the prescribing doctor based on patient response and overall health. Proper handling and administration play a crucial role in maximizing effectiveness and minimizing risk.

Packaging and Quality Assurance

Packaged in a durable glass vial with a protective flip-off seal, Bortecad ensures secure storage of the medication's lyophilized powder form. Manufactured in WHO-GMP and ISO-certified facilities in India, its pharmaceutical grade quality and strict adherence to international standards guarantee safety and efficacy for every batch distributed.

FAQ's of Bortezomib Injection:

Q: How should Bortecad (Bortezomib Injection) be prepared and administered?

A: Bortecad must be reconstituted with sterile water for injection by a healthcare professional before use. Once properly diluted, it is administered either intravenously or subcutaneously in a clinical setting.

Q: What conditions is Bortecad commonly used to treat?

A: Bortecad is mainly prescribed for the management of multiple myeloma and mantle cell lymphoma, two types of cancers affecting the blood and lymphatic system.

Q: When should Bortecad injection be given to patients?

A: The injection is given according to a dosing schedule determined by the prescribing doctor, tailored to the patient's specific type of cancer, treatment cycle, and individual response to therapy.

Q: Where should Bortecad be stored before use?

A: Store Bortecad below 30C and protect it from light to maintain its potency and stability until use. It should be kept in its original glass vial until reconstitution.

Q: What are the main benefits of using Bortecad for eligible patients?

A: Bortecad is a targeted therapy that helps slow the growth of cancerous cells, offering an effective option for patients with multiple myeloma or mantle cell lymphoma. Its pharmaceutical grade assures consistent efficacy and safety.

Q: Is a prescription required to obtain Bortecad (Bortezomib Injection)?

A: Yes, Bortecad is a prescription medication and should only be used under the supervision of a qualified healthcare provider.

Q: What are the inactive ingredients in Bortecad and why are they important?

A: In addition to Bortezomib, Bortecad contains mannitol as an inactive ingredient, which helps stabilize the lyophilized powder for proper reconstitution and consistent dosing.

Tell us about your requirement